- ICH GCP
- US Clinical Trials Registry
- Search trials
Kliniske forsøg sponsoreret af Govt Medical College & Hospital, Bhavnagar
I alt 2243 resultater
-
Peking Union Medical College HospitalIkke rekrutterer endnuOralt planocellulært karcinomKina
-
Peking Union Medical College HospitalRekrutteringAutoimmune sygdommeKina
-
Peking Union Medical College HospitalRekruttering
-
Peking Union Medical College HospitalRekrutteringKræft i bugspytkirtlen | Ultralyd | Første linje kemoterapiKina
-
Peking Union Medical College HospitalRekruttering
-
Peking Union Medical College HospitalIkke rekrutterer endnuEffekt og sikkerhed af Surufatinib kombineret med Envafolimab som anden eller mere linie terapi hos avancerede bløddelssarkompatienter
-
Peking Union Medical College HospitalRekruttering
-
Peking Union Medical College HospitalRekrutteringSlag | Kræft- og kræftbehandlingsrelaterede tilstandeKina
-
Peking Union Medical College HospitalRekrutteringUltralydsterapi; Komplikationer | Lungeskade, akutKina
-
Peking Union Medical College HospitalIkke rekrutterer endnuMyofascial smerte
-
Peking Union Medical College HospitalRekrutteringEndometriale neoplasmerKina
-
Peking Union Medical College HospitalRekrutteringMetastatisk kastrationsresistent prostatakræftKina
-
Peking Union Medical College HospitalRekrutteringSikkerhedsproblemer | Effektivitet, SelvKina
-
Peking Union Medical College HospitalRekrutteringForhøjet blodtryk | Fedme | Diabetes mellitus | Kroniske nyresygdomme | HyperurikæmiKina
-
Peking Union Medical College HospitalIkke rekrutterer endnu
-
Peking Union Medical College HospitalRekrutteringIkke-småcellet lungekræftKina
-
Peking Union Medical College HospitalRekrutteringEndetarmskræft | Tyktarmskræft | Kemoterapi effekt | PTC | Exon mutationKina
-
Peking Union Medical College HospitalRekruttering
-
Peking Union Medical College HospitalRekruttering
-
Peking Union Medical College HospitalRekruttering
-
Peking Union Medical College HospitalRekrutteringNyrecellekarcinomKina
-
Peking Union Medical College HospitalRekrutteringEffekt og sikkerhed af Camrelizumab Plus S-1 vedligeholdelse efter førstelinjeinduktionskemoterapi til GCKina
-
Peking Union Medical College HospitalIkke rekrutterer endnu
-
Peking Union Medical College HospitalIkke rekrutterer endnu
-
Peking Union Medical College HospitalRekruttering
-
Peking Union Medical College HospitalRekruttering
-
Peking Union Medical College HospitalIkke rekrutterer endnuUltralyd | Intubationskomplikation | Intubation; Svært eller mislykket | Diagnostisk billeddannelse
-
Peking Union Medical College HospitalRekruttering
-
Peking Union Medical College HospitalRekruttering
-
Peking Union Medical College HospitalIkke rekrutterer endnuVaginalt mikrobiom | Graft Versus Host Reaktion
-
Peking Union Medical College HospitalRekruttering
-
Peking Union Medical College HospitalRekrutteringIntravaskulært stort B-cellet lymfomKina
-
Peking Union Medical College HospitalRekrutteringIdiopatisk retroperitoneal fibroseKina
-
Peking Union Medical College HospitalRekruttering
-
Peking Union Medical College HospitalRekruttering
-
Peking Union Medical College HospitalRekrutteringSmerter, postoperativKina
-
Peking Union Medical College HospitalRekrutteringPrimær biliær kolangitisKina
-
Peking Union Medical College HospitalRekruttering
-
Peking Union Medical College HospitalRekrutteringHypertension, RenovaskulærKina
-
Peking Union Medical College HospitalIkke rekrutterer endnuLivmoderhalskræft | Kemoterapi
-
Peking Union Medical College HospitalIkke rekrutterer endnuDiabetes mellitus | Akut nyreskade | Neuromuskulær blokade | Laparoskopisk kirurgisk indgreb
-
Peking Union Medical College HospitalIkke rekrutterer endnu
-
Peking Union Medical College HospitalRekruttering
-
Peking Union Medical College HospitalRekruttering
-
Peking Union Medical College HospitalRekruttering
-
Peking Union Medical College HospitalRekruttering
-
Peking Union Medical College HospitalRekruttering
-
Peking Union Medical College HospitalRekruttering
-
Peking Union Medical College HospitalRekruttering
-
Peking Union Medical College HospitalRekrutteringPrimært intraokulært lymfomKina